MITOMYCIN — all Canadian products
9 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is MITOMYCIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02557762 | MITOMYCIN FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravesicular; Intravenous | MITOMYCIN 20 MG | Approved | |
| 02230451 | MITOMYCIN FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | Intravenous; Intravesical | MITOMYCIN 20 MG | Marketed | |
| 02464691 | MITOMYCIN FOR INJECTION USP | ACCORD HEALTHCARE INC | Powder For Solution | Intravenous; Intravesical | MITOMYCIN 20 MG | Marketed | |
| 02531941 | MITOMYCIN FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | Intravesical; Intravenous | MITOMYCIN 20 MG | Marketed | |
| 02230450 | MITOMYCIN FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | Intravesical; Intravenous | MITOMYCIN 5 MG | Cancelled Post Market | |
| 02230729 | MITOMYCIN FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravenous; Intravesical | MITOMYCIN 20 MG | Cancelled Post Market | |
| 02237745 | MITOMYCIN FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravenous; Intravesical | MITOMYCIN 5 MG | Cancelled Post Market | |
| 00587710 | MUTAMYCIN INJ 20MG/VIAL | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | Intravesical; Intravenous | MITOMYCIN 20 MG | Cancelled Post Market | |
| 00381799 | MUTAMYCIN INJ 5MG/VIAL | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | Intravesical; Intravenous | MITOMYCIN 0.5 MG | Cancelled Post Market |
Browse other molecules: